Pavić K - Search Results

1

Primaquine hybrids as promising antimycobacterial and antimalarial agents.

Pavić K, Perković I, Pospíšilová Š, Machado M, Fontinha D, Prudêncio M, Jampilek J, Coffey A, Endersen L, Rimac H, Zorc B. Pavić K, et al. Eur J Med Chem. 2018 Jan 1;143:769-779. doi: 10.1016/j.ejmech.2017.11.083. Epub 2017 Dec 2. Eur J Med Chem. 2018. PMID: 29220797

2

Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity.

Pavić K, Perković I, Cindrić M, Pranjić M, Martin-Kleiner I, Kralj M, Schols D, Hadjipavlou-Litina D, Katsori AM, Zorc B. Pavić K, et al. Eur J Med Chem. 2014 Oct 30;86:502-14. doi: 10.1016/j.ejmech.2014.09.013. Epub 2014 Sep 6. Eur J Med Chem. 2014. PMID: 25203780

3

Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.

Perković I, Antunović M, Marijanović I, Pavić K, Ester K, Kralj M, Vlainić J, Kosalec I, Schols D, Hadjipavlou-Litina D, Pontiki E, Zorc B. Perković I, et al. Among authors: pavic k. Eur J Med Chem. 2016 Nov 29;124:622-636. doi: 10.1016/j.ejmech.2016.08.021. Epub 2016 Aug 24. Eur J Med Chem. 2016. PMID: 27614409

4

Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type.

Pavić K, Perković I, Gilja P, Kozlina F, Ester K, Kralj M, Schols D, Hadjipavlou-Litina D, Pontiki E, Zorc B. Pavić K, et al. Molecules. 2016 Nov 28;21(12):1629. doi: 10.3390/molecules21121629. Molecules. 2016. PMID: 27916811 Free PMC article.

5

Insights into biological activity of ureidoamides with primaquine and amino acid moieties.

Vlainić J, Kosalec I, Pavić K, Hadjipavlou-Litina D, Pontiki E, Zorc B. Vlainić J, et al. Among authors: pavic k. J Enzyme Inhib Med Chem. 2018 Dec;33(1):376-382. doi: 10.1080/14756366.2017.1423067. J Enzyme Inhib Med Chem. 2018. PMID: 29363364 Free PMC article.

6

Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.

Levatić J, Pavić K, Perković I, Uzelac L, Ester K, Kralj M, Kaiser M, Rottmann M, Supek F, Zorc B. Levatić J, et al. Among authors: pavic k. Eur J Med Chem. 2018 Feb 25;146:651-667. doi: 10.1016/j.ejmech.2018.01.062. Epub 2018 Jan 31. Eur J Med Chem. 2018. PMID: 29407988

7

Second generation of primaquine ureas and bis-ureas as potential antimycobacterial agents.

Pavić K, Rajić Z, Michnová H, Jampílek J, Perković I, Zorc B. Pavić K, et al. Mol Divers. 2019 Aug;23(3):657-667. doi: 10.1007/s11030-018-9899-z. Epub 2018 Dec 6. Mol Divers. 2019. PMID: 30523579

8

Insights into the mechanism of antiproliferative effects of primaquine-cinnamic acid conjugates on MCF-7 cells.

Mabeta P, Pavić K, Zorc B. Mabeta P, et al. Among authors: pavic k. Acta Pharm. 2018 Sep 1;68(3):337-348. doi: 10.2478/acph-2018-0021. Acta Pharm. 2018. PMID: 31259699 Free article.

9

Primaquine homodimers as potential antiplasmodial and anticancer agents.

Pavić K, Rubinić B, Rajić Z, Fontinha D, Prudêncio M, Uzelac L, Kralj M, Held J, Zorc B. Pavić K, et al. Bioorg Med Chem Lett. 2019 Oct 1;29(19):126614. doi: 10.1016/j.bmcl.2019.08.018. Epub 2019 Aug 10. Bioorg Med Chem Lett. 2019. PMID: 31431364

10

Primaquine derivatives: Modifications of the terminal amino group.

Zorc B, Perković I, Pavić K, Rajić Z, Beus M. Zorc B, et al. Among authors: pavic k. Eur J Med Chem. 2019 Nov 15;182:111640. doi: 10.1016/j.ejmech.2019.111640. Epub 2019 Aug 23. Eur J Med Chem. 2019. PMID: 31472472 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters